SCIENTURE HOLDINGS, INC. Cash Provided by (Used in) Financing Activities, Discontinued Operations
SCIENTURE HOLDINGS, INC. (SCNX) reported Cash Provided by (Used in) Financing Activities, Discontinued Operations of -$5.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Cash Flow › Financing Activities
us-gaap:CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations · last filed 2026-03-30
- SCIENTURE HOLDINGS, INC. cash provided by (used in) financing activities, discontinued operations for the quarter ending 2024-12-31 was $0.00.
- SCIENTURE HOLDINGS, INC. cash provided by (used in) financing activities, discontinued operations for the quarter ending 2024-09-30 was $0.00.
- SCIENTURE HOLDINGS, INC. cash provided by (used in) financing activities, discontinued operations for the quarter ending 2024-06-30 was $0.00.
- SCIENTURE HOLDINGS, INC. cash provided by (used in) financing activities, discontinued operations for the quarter ending 2024-03-31 was -$5.00K.
- SCIENTURE HOLDINGS, INC. cash provided by (used in) financing activities, discontinued operations for fiscal 2024 was -$5.00K.
- SCIENTURE HOLDINGS, INC. cash provided by (used in) financing activities, discontinued operations for fiscal 2023 was -$500.00K.
- SCIENTURE HOLDINGS, INC. cash provided by (used in) financing activities, discontinued operations for fiscal 2022 was -$275.00K.
- SCIENTURE HOLDINGS, INC. cash provided by (used in) financing activities, discontinued operations for fiscal 2017 was $0.00, a 100.00% decline from fiscal 2016.
| Period end | Cash Provided by (Used in) Financing Activities, Discontinued Operations 3 month | Cash Provided by (Used in) Financing Activities, Discontinued Operations 6 month | Cash Provided by (Used in) Financing Activities, Discontinued Operations 9 month | Cash Provided by (Used in) Financing Activities, Discontinued Operations 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $0.00 derived: sum of 2 quarters · filed 2026-03-30 | $0.00 derived: sum of 3 quarters · filed 2026-03-30 | -$5.00K 10-K · filed 2026-03-30 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $0.00 derived: sum of 2 quarters · filed 2025-11-12 | -$5.00K 10-Q · filed 2025-11-12 | -$5.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$5.00K 10-Q · filed 2025-08-12 | -$5.00K derived: sum of 3 quarters · filed 2025-08-12 | |
| 2024-03-31 | -$5.00K 10-Q · filed 2025-05-12 | -$5.00K derived: sum of 2 quarters · filed 2025-05-12 | ||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | -$500.00K 10-K · filed 2025-03-26 | ||
| 2023-09-30 | -$500.00K 10-Q · filed 2024-11-06 | |||
| 2022-12-31 | -$275.00K 10-K · filed 2024-04-22 | |||
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-18 | -$275.00K 10-Q · filed 2023-08-18 | ||
| 2022-03-31 | -$275.00K 10-Q · filed 2023-05-15 | |||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-02 | $0.00 derived: sum of 2 quarters · filed 2018-03-02 | $0.00 10-K · filed 2018-03-02 | |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $0.00 10-Q · filed 2017-11-07 | ||
| 2017-06-30 | $0.00 10-Q · filed 2017-08-04 | |||
| 2016-12-31 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-02 | $300.00K derived: sum of 2 quarters · filed 2018-03-02 | $550.00K 10-K · filed 2018-03-02 | |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $250.00K 10-Q · filed 2017-11-07 | ||
| 2016-06-30 | $250.00K 10-Q · filed 2017-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |